文献速递消化与肝胆胰病理细胞病理与分子病理

胰腺囊性病变:鉴别诊断与细胞-组织学相关性

Cystic Lesions of the Pancreas: Differential Diagnosis and Cytologic-Histologic Correlation.
PubMed 文献 · Arch Pathol Lab Med · 2019-09-20

胰腺囊性病变(PCLs)常见且检出率随影像进步而增加,区分肿瘤性与非肿瘤性对处理至关重要。内镜超声引导细针穿刺(EUS-FNA)细胞学联合囊液分析有助于鉴别低风险与高风险囊肿,但细胞量少使细胞学确诊具有挑战性。准确诊断需整合临床、影像、细胞学、囊液分析及分子检测的多学科多模态方法。

要点

  • 胰腺囊性病变需区分肿瘤性与非肿瘤性,后者无恶变风险。
  • EUS-FNA细胞学联合囊液分析可辅助鉴别低风险与高风险囊肿。
  • 细胞学标本细胞量少,确诊困难,需多学科多模态整合诊断。

核心结论

  • 胰腺囊性病变的准确诊断需要多学科多模态团队方法,整合临床、影像、细胞学、囊液分析及分子检测。

研究设计与样本

  • 综述与分析描述胰腺囊性病变的最新文献。

主要发现

  • 肿瘤性囊肿包括潜在恶变的黏液性囊肿(导管内乳头状黏液性肿瘤和黏液性囊性肿瘤)和非黏液性囊肿(实性假乳头状肿瘤、浆液性囊性肿瘤及囊性变神经内分泌肿瘤)。
  • 非肿瘤性囊肿无恶变风险,包括假性囊肿、潴留囊肿、淋巴上皮囊肿、胰腺囊性淋巴管瘤及重复囊肿/纤毛前肠囊肿。
  • EUS-FNA细胞学联合囊液分析在PCLs诊断中的作用在过去十年有所发展,但细胞量少使细胞学确诊具有挑战性。
  • EUS-FNA可帮助区分低风险与高风险胰腺囊肿,并鉴别需要临床随访与需要手术的患者。

临床怎么用

  • 利用EUS-FNA细胞学与囊液分析辅助区分低风险与高风险胰腺囊肿。
  • 结合临床、影像、细胞学、囊液分析及分子检测进行多学科综合诊断。

局限性

  • 细胞学标本细胞量少, definitive诊断受限于此,具有挑战性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT.—: Pancreatic cystic lesions (PCLs) are very common, and their detection is increasing with the advances in imaging techniques. Because of the major implications for management, distinguishing between neoplastic and nonneoplastic PCLs is critical. Neoplastic cysts with potential to progress into cancer include mucinous PCLs (intraductal papillary mucinous neoplasms and mucinous cystic neoplasms) and nonmucinous cysts (solid pseudopapillary tumors, serous cystic neoplasms, and neuroendocrine tumors with cystic degeneration). Nonneoplastic cysts with no risk of malignant transformation include pseudocysts, retention cysts, lymphoepithelial cysts, cystic pancreatic lymphangioma, and duplication cyst/ciliated foregut cysts. The role of endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) cytology with cyst fluid analysis in the diagnosis of PCLs has evolved during the last decade; however, a definitive diagnosis on cytologic specimens is hampered by the sparse cellularity and can be challenging. EUS-FNA can play an important role to differentiate low-risk from high-risk pancreatic cysts and to distinguish between patients with cysts who need clinical follow-up versus those who require surgery. OBJECTIVE.—: To provide an integrative approach to diagnose pancreatic cystic lesions using EUS-FNA cytology and cyst fluid analysis, along with clinical, radiologic, histologic, genetic, and molecular characteristics. DATA SOURCES.—: The review and analysis of the latest literature describing pancreatic cystic lesions. CONCLUSIONS.—: Accurate diagnosis of PCLs requires a multidisciplinary and multimodal team approach, including the integration of clinical findings, imaging, cytology, cyst fluid analysis, and molecular testing.

来源:Arch Pathol Lab Med,查看原文。版权归原作者所有。

引用

  1. Abdelkader A, Hunt B, Hartley CP, et al. Cystic Lesions of the Pancreas: Differential Diagnosis and Cytologic-Histologic Correlation. Arch Pathol Lab Med. 2019. PMID: 31538798. doi:10.5858/arpa.2019-0308-RA

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。